Observations indicate that patients with different subtypes of myasthenia gravis, associated with the presence of different antibodies—AChR, MuSK, or against lipoprotein receptor-related protein 4 (LRP4)—present similar clinical symptoms, regardless of the mechanism of immunopathology [25]. The gene discussed is MUSK; the disease is myasthenia gravis.